China Health Group (00673) has announced that on February 2, 2026, the company entered into a subscription agreement with the subscriber, Hong Kong Riheng Limited (wholly owned by Zhang Xiaoling). Pursuant to the agreement, the company has agreed to allot and issue (under a general mandate), and the subscriber has agreed to subscribe for, a total of 48 million subscription shares at a price of HK$0.53 per share. The total of 48 million subscription shares represents approximately 3.58% of the total existing issued shares as of the date of this announcement and about 3.46% of the total issued share capital as enlarged immediately after completion (assuming no changes to the company's issued share capital between the date of this announcement and the completion date). The subscription price of HK$0.53 per share represents a discount of approximately 13.11% compared to the closing price of HK$0.61 per share as quoted on the Stock Exchange on the last trading day. The gross proceeds from the subscription and the net proceeds (after deducting related expenses) will be approximately HK$25.44 million and HK$25.27 million, respectively. The net issue price will be approximately HK$0.526 per subscription share.